{"pmid":32243612,"title":"WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): From Bedside to Phone-side.","text":["WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): From Bedside to Phone-side.","The current coronavirus disease (COVID-19) has forced the shutdown of many non-essential services in most of the high-risk countries. Most of the consultations (except emergencies) in dermatology are deferred as a precautionary measure to prevent the spread of COVID-19.","Clin Exp Dermatol","Deepak, J","Subuhi, K","Ishmeet, K","32243612"],"abstract":["The current coronavirus disease (COVID-19) has forced the shutdown of many non-essential services in most of the high-risk countries. Most of the consultations (except emergencies) in dermatology are deferred as a precautionary measure to prevent the spread of COVID-19."],"journal":"Clin Exp Dermatol","authors":["Deepak, J","Subuhi, K","Ishmeet, K"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243612","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ced.14227","keywords":["COVID-19","coronavirus","social distancing","teledermatology","telemedicine","whatsapp"],"source":"PubMed","locations":["Bedside"],"topics":["Prevention"],"weight":1,"_version_":1663079112821964800,"score":7.6048946,"similar":[{"pmid":32238000,"title":"Teledermatology: a useful tool to fight COVID-19.","text":["Teledermatology: a useful tool to fight COVID-19.","J Dermatolog Treat","Villani, Alessia","Scalvenzi, Massimiliano","Fabbrocini, Gabriella","32238000"],"journal":"J Dermatolog Treat","authors":["Villani, Alessia","Scalvenzi, Massimiliano","Fabbrocini, Gabriella"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238000","week":"202014|Mar 30 - Apr 05","doi":"10.1080/09546634.2020.1750557","keywords":["COVID-19","coronavirus","dermatology","prevention","teledermatology","telemedicine"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662996001762312193,"score":180.32803},{"pmid":32238336,"title":"Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.","text":["Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.","On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported in more than 203 countries as of 31 March. The response strategy included early diagnosis, patient isolation, symptomatic monitoring of contacts as well as suspected and confirmed cases, and public health quarantine. In this context, telemedicine, particularly video consultations, has been promoted and scaled up to reduce the risk of transmission, especially in the United Kingdom and the United States of America. Based on a literature review, the first conceptual framework for telemedicine implementation during outbreaks was published in 2015. An updated framework for telemedicine in the COVID-19 pandemic has been defined. This framework could be applied at a large scale to improve the national public health response. Most countries, however, lack a regulatory framework to authorize, integrate, and reimburse telemedicine services, including in emergency and outbreak situations. In this context, Italy does not include telemedicine in the essential levels of care granted to all citizens within the National Health Service, while France authorized, reimbursed, and actively promoted the use of telemedicine. Several challenges remain for the global use and integration of telemedicine into the public health response to COVID-19 and future outbreaks. All stakeholders are encouraged to address the challenges and collaborate to promote the safe and evidence-based use of telemedicine during the current pandemic and future outbreaks. For countries without integrated telemedicine in their national health care system, the COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for supporting wide adoption of telemedicine.","JMIR Public Health Surveill","Ohannessian, Robin","Duong, Tu Anh","Odone, Anna","32238336"],"abstract":["On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported in more than 203 countries as of 31 March. The response strategy included early diagnosis, patient isolation, symptomatic monitoring of contacts as well as suspected and confirmed cases, and public health quarantine. In this context, telemedicine, particularly video consultations, has been promoted and scaled up to reduce the risk of transmission, especially in the United Kingdom and the United States of America. Based on a literature review, the first conceptual framework for telemedicine implementation during outbreaks was published in 2015. An updated framework for telemedicine in the COVID-19 pandemic has been defined. This framework could be applied at a large scale to improve the national public health response. Most countries, however, lack a regulatory framework to authorize, integrate, and reimburse telemedicine services, including in emergency and outbreak situations. In this context, Italy does not include telemedicine in the essential levels of care granted to all citizens within the National Health Service, while France authorized, reimbursed, and actively promoted the use of telemedicine. Several challenges remain for the global use and integration of telemedicine into the public health response to COVID-19 and future outbreaks. All stakeholders are encouraged to address the challenges and collaborate to promote the safe and evidence-based use of telemedicine during the current pandemic and future outbreaks. For countries without integrated telemedicine in their national health care system, the COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for supporting wide adoption of telemedicine."],"journal":"JMIR Public Health Surveill","authors":["Ohannessian, Robin","Duong, Tu Anh","Odone, Anna"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238336","week":"202014|Mar 30 - Apr 05","doi":"10.2196/18810","keywords":["COVID-19","SARS-CoV-2","coronavirus","digital health","digital medicine","outbreak","pandemic","public health","surveillance","telehealth","telemedicine"],"source":"PubMed","locations":["United Kingdom","France","Italy"],"countries":["Italy","United Kingdom","France"],"countries_codes":["ITA|Italy","GBR|United Kingdom","FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1662996001801109505,"score":110.76391},{"pmid":32241193,"title":"COVID-19: Challenges and opportunities for dermatology response.","text":["COVID-19: Challenges and opportunities for dermatology response.","As the world faces an unprecedented challenge in the novel coronavirus disease-2019 (COVID-19) pandemic, which as of 21 March 2020 has had 287,239 confirmed cases and 11,921 number of deaths worldwide, its consequences have reached all facets of medicine, including dermatology.(1) It remains a rapidly evolving scenario with guidance being updated regularly to reflect new information. Whilst it presents unique challenges to dermatology, it also presents an opportunity to help drive the development of new infrastructure to adapt and improve dermatology practice.","J Dermatolog Treat","Chawla, S","32241193"],"abstract":["As the world faces an unprecedented challenge in the novel coronavirus disease-2019 (COVID-19) pandemic, which as of 21 March 2020 has had 287,239 confirmed cases and 11,921 number of deaths worldwide, its consequences have reached all facets of medicine, including dermatology.(1) It remains a rapidly evolving scenario with guidance being updated regularly to reflect new information. Whilst it presents unique challenges to dermatology, it also presents an opportunity to help drive the development of new infrastructure to adapt and improve dermatology practice."],"journal":"J Dermatolog Treat","authors":["Chawla, S"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241193","week":"202014|Mar 30 - Apr 05","doi":"10.1080/09546634.2020.1751040","keywords":["COVID-19","outpatient","teledermatology"],"source":"PubMed","weight":0,"_version_":1663079112881733632,"score":100.20178},{"pmid":32232915,"title":"COVID-19 Pandemic - Is Virtual Urology Clinic the answer to keeping the cancer pathway moving?","text":["COVID-19 Pandemic - Is Virtual Urology Clinic the answer to keeping the cancer pathway moving?","The COVID-19 pandemic presents an unprecedented challenge to our National Health Service (NHS) (1). As the need to appropriately direct all efforts towards providing emergency supportive care to those suffering, there will be a knee-jerk tendency to cancel all outpatient activity by NHS trusts. Whilst this appears to be a pragmatic approach to reducing risk of transmission, there will be an unmet cost to those patients who are high-risk and are already on the cancer referral pathway.","BJU Int","Connor, M J","Winkler, M","Miah, S","32232915"],"abstract":["The COVID-19 pandemic presents an unprecedented challenge to our National Health Service (NHS) (1). As the need to appropriately direct all efforts towards providing emergency supportive care to those suffering, there will be a knee-jerk tendency to cancel all outpatient activity by NHS trusts. Whilst this appears to be a pragmatic approach to reducing risk of transmission, there will be an unmet cost to those patients who are high-risk and are already on the cancer referral pathway."],"journal":"BJU Int","authors":["Connor, M J","Winkler, M","Miah, S"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32232915","week":"202014|Mar 30 - Apr 05","doi":"10.1111/bju.15061","keywords":["COVID-19","telehealth","telemedicine","urology virtual clinic"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662899337775022081,"score":99.53594},{"pmid":32141058,"title":"Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department.","text":["Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department.","As of Feb 15, 2020, the novel coronavirus (2019-nCoV) has rapidly spread throughout China and across the world with more than 60,000 laboratory-confirmed cases. Due to the current lack of specific treatment and the risk of transmission during the viral incubation period, infection prevention and control of 2019-nCoV are both urgent and critical to global health. In this article, we aim to highlight the necessity of implementing protective measures, and recommend how to set proper emergency management plans for preventing and controlling nosocomial infection of 2019-nCoV in dermatology departments.","Br J Dermatol","Tao, J","Song, Z","Yang, L","Huang, C","Feng, A","Man, X","32141058"],"abstract":["As of Feb 15, 2020, the novel coronavirus (2019-nCoV) has rapidly spread throughout China and across the world with more than 60,000 laboratory-confirmed cases. Due to the current lack of specific treatment and the risk of transmission during the viral incubation period, infection prevention and control of 2019-nCoV are both urgent and critical to global health. In this article, we aim to highlight the necessity of implementing protective measures, and recommend how to set proper emergency management plans for preventing and controlling nosocomial infection of 2019-nCoV in dermatology departments."],"journal":"Br J Dermatol","authors":["Tao, J","Song, Z","Yang, L","Huang, C","Feng, A","Man, X"],"date":"2020-03-07T11:00:00Z","year":2020,"_id":"32141058","week":"202010|Mar 02 - Mar 08","doi":"10.1111/bjd.19011","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1662334543958376448,"score":72.09629}]}